5-fu
Showing 26 - 50 of 123
Treatment Related Cancer Trial in Munich (5-FU, Folinic Acid, Irinotecan)
Active, not recruiting
- Treatment Related Cancer
- 5-FU
- +4 more
-
Munich, GermanyLudwig Maximilians University
Jan 19, 2022
Metastatic Colorectal Cancer Trial in Beijing (Bevacizumab, Capecitabine, Irinotecan)
Completed
- Metastatic Colorectal Cancer
- Bevacizumab
- +4 more
-
Beijing, ChinaCancer Hospital & Institute, Chinese Academy of Medical Sciences
Mar 9, 2022
Metastatic Colorectal Cancer Trial in Kaohsiung (UGT1A1 genotyping (6,6), UGTIA1 genotyping (6,7), UGTIA1 genotyping (7,7))
Completed
- Metastatic Colorectal Cancer
- UGT1A1 genotyping (6,6)
- +7 more
-
Kaohsiung, TaiwanChung-Ho Memorial Hospital, Kaohsiung Medical University:
Nov 9, 2021
Stomach Tumors, Gastrointestinal Tumors, Docetaxel Trial in Moscow (Irinotecan, 5-FU, Leucovorin)
Recruiting
- Stomach Neoplasms
- +5 more
- Irinotecan
- +4 more
-
Moscow, Russian FederationAleksei Kalinin
Apr 12, 2021
HPV-Related Squamous Cell Carcinoma, HNSCC Trial in Chicago (drug, procedure, radiation)
Active, not recruiting
- HPV-Related Squamous Cell Carcinoma
- HNSCC
- nab-paclitaxel
- +12 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Nov 12, 2021
Pancreatic Cancer Trial in Worldwide (5-FU, Oxaliplatine, Irinotecan)
Active, not recruiting
- Pancreatic Cancer
- 5-FU
- +3 more
-
Odense, Denmark
- +12 more
Jun 25, 2021
Tumors Trial in Worldwide (5-FU, Docetaxel, Enzalutamide)
Completed
- Neoplasms
- 5-FU
- +6 more
-
San Francisco, California
- +10 more
Jan 6, 2022
Colorectal Cancer Trial in Montpellier (Oxaliplatin, Folinic Acid, 5-FU)
Completed
- Colorectal Cancer
- Oxaliplatin
- +5 more
-
Montpellier, FranceCentre Val d'Aurelle
Jun 14, 2021
Squamous Cell Carcinoma of the Head and Neck Trial in Saint Louis (Abraxane, Cetuximab, Cisplatin)
Completed
- Squamous Cell Carcinoma of the Head and Neck
- Abraxane
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 21, 2020
Esophageal Cancer Trial in Houston (drug, radiation, procedure)
Completed
- Esophageal Cancer
- Docetaxel
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 12, 2021
Gastric Cancer Trial in Shanghai (PD-1 inhibitor, Oxaliplatin, Capecitabine)
Recruiting
- Gastric Cancer
- PD-1 inhibitor
- +6 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 1, 2021
Colorectal Cancer, Metastatic Colorectal Cancer, RAS Mutation Trial in Italy (Bevacizumab, Cetuximab, 5-FU)
Recruiting
- Colorectal Cancer
- +2 more
- Bevacizumab
- +4 more
-
Coppito, L'Aquila, Italy
- +3 more
Sep 10, 2021
Pancreatic Adenocarcinoma Trial in Seattle (Gemcitabine, nab paclitaxel, Onivyde)
Recruiting
- Pancreatic Adenocarcinoma
- Gemcitabine
- +4 more
-
Seattle, WashingtonVirginia mason medical Center
Jan 25, 2021
Tumor, Esophageal, Squamous Cell Carcinoma Trial in Guanzhou (drug, radiation, device)
Recruiting
- Neoplasm, Esophageal
- Squamous Cell Carcinoma
- Paclitaxel
- +6 more
-
Guanzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 21, 2021
Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Magrolimab, Pembrolizumab, Docetaxel)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Magrolimab
- +6 more
-
Chandler, Arizona
- +59 more
Jan 20, 2023
Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)
Recruiting
- Solid Tumor
- +11 more
- TRK-950
- +14 more
-
Scottsdale, Arizona
- +13 more
Oct 2, 2022
Colorectal Cancer Metastatic Trial in Spain (Panitumumab, Irinotecan, Folinic acid)
Active, not recruiting
- Colorectal Cancer Metastatic
- Panitumumab
- +3 more
-
Gerona, Barcelona, Spain
- +17 more
Jun 29, 2021
Malignant Solid Tumor, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial in Worldwide (GEN1042, Pembrolizumab,
Recruiting
- Malignant Solid Tumor
- +5 more
- GEN1042
- +8 more
-
San Diego, California
- +27 more
Dec 24, 2022
Pancreatic Cancer Trial in Houston (Oxaliplatin, Irinotecan, 5-FU)
Completed
- Pancreatic Cancer
- Oxaliplatin
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 24, 2020
Advanced Solid Tumor Malignancies Trial in Washington (PD-0332991, 5-FU, Oxaliplatin)
Unknown status
- Advanced Solid Tumor Malignancies
- PD-0332991
- +2 more
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Mar 2, 2020
Colorectal Tumors, Colorectal Carcinoma, Colorectal Cancer Metastatic Trial in Spain (Panitumumab, Irinotecan, Folinic acid)
Completed
- Colorectal Neoplasms
- +3 more
- Panitumumab
- +3 more
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +11 more
Jun 18, 2021
Solid Tumor Trial in Worldwide (5-FU, Atezolizumab, Bevacizumab)
Completed
- Solid Tumor
- 5-FU
- +8 more
-
Palo Alto, California
- +29 more
Jul 8, 2021
Stage II Rectal Cancer, Stage III Rectal Cancer Trial in Dallas (drug, radiation, procedure)
Withdrawn
- Stage II Rectal Cancer
- Stage III Rectal Cancer
- Capecitabine
- +5 more
-
Dallas, TexasUT Southwestern Medical Center
Aug 19, 2020